NIH Tests Fecal Transplant in Chronic Granulomatous Disease-Associated Colitis
Researchers at NIH are testing a new therapy in patients diagnosed with colitis due to chronic granulomatous disease (CGD). The research aims to see if restoring the gut microbiome reduces inflammation in the colon.
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous ZMA001 in Healthy Subjects
Natural History Study of CADASIL
Investigational Dietary Supplements and Keto Sleep Calories
Dr. Stephanie Chung and her team at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking male volunteers aged 18-65 for a study on the impact of low-carb (ketogenic) diets, with or without an investigational dietary supplement called nicotinamide riboside, on energy levels and metabolism during sleep.